Helus Pharma has revealed data from a phase 3 trial of HLP003 that showed evidence of efficacy in major depressive disorder ...
Novo has published the results of a clinical trial of its Wegovy injection in children aged six to 12 with obesity, showing ...
New Orleans hosted this year’s AAPS PharmSci 360 at the Ernest N. Morial Convention Center. For those fortunate enough to ...
AstraZeneca's rare disease unit Alexion has won regulatory approval in the US and EU for Klygefa as a generalised myasthenia ...
Medical technology company Boston Scientific became the target of a cyberattack this week, which disrupted some of its IT systems, causing operational disruptions globally. The company detected the ...
Eli Lilly has added yet another name to its list of M&A deals this year after agreeing to buy blood disorder specialist Calytrix Bio for up to $1.5 billion. If it goes through, the deal will give ...
China has overtaken Europe as the preferred location for healthcare investing, according to a new report from Jefferies, ...
The FDA has said it cannot approve Summit Therapeutics and Akeso's PD-1xVEGF inhibitor ivonescimab, delaying a drug that is ...
Berkeley Heights, NJ – April 15, 2026: Axtria Inc., a global leader in AI-first data analytics solutions for the life sciences industry, today announced the acquisition of Conexus Solutions, a premier ...
Eledon Pharmaceuticals has revealed that two patients with type 1 diabetes achieved a 'functional cure' after receiving a transplant of insulin-producing islet cells in combination with its ...
Asundexian has been approved by the FDA under the Sunharbo brand name for use in combination with antiplatelet therapy to ...
Just a few months after being formed, China's Funnel Biosciences has signed a $2 billion-plus partnership with Third Rock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results